Universal Health Services (UHS)
(Delayed Data from NYSE)
$205.26 USD
+0.95 (0.46%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $205.49 +0.23 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$205.26 USD
+0.95 (0.46%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $205.49 +0.23 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Zacks News
Reasons to Hold Patterson Companies (PDCO) in Your Portfolio Now
by Zacks Equity Research
Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.
Stryker's (SYK) Pangea System to Enhance Plating Solutions
by Zacks Equity Research
Stryker (SYK) announces the launch of its Pangea Plating System, which is likely to provide solutions for internal fixation and stabilization of bone fractures.
PacBio (PACB) Q2 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
PacBio's (PACB) Product revenues decline in the second quarter of 2024. However, Consumable and Service and other revenues increase year over year.
Vicarious Surgical (RBOT) Partners LSU Health New Orleans
by Zacks Equity Research
Vicarious Surgical (RBOT) teams up with LSU Health New Orleans to advance its V1.0 surgical robot. It aims to file for FDA approval by 2026.
McKesson (MCK) Q1 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
McKesson's (MCK) first-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
Smith & Nephew (SNN), HOPCo to Enhance Musculoskeletal Care
by Zacks Equity Research
Smith & Nephew (SNN) announces a collaboration with HOPCo to focus on enhancing solutions for ASC customers, physicians, and patients through the latter's digital health and analytics platforms.
Nevro's (NVRO) Q2 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Nevro's (NVRO) second-quarter earnings beat the Zacks Consensus Estimate while worldwide revenues decline year over over. The company incurs a loss at the operating level.
Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Inogen's (INGN) second-quarter 2024 results reflect significant improvement in the top and bottom lines, driven by strong international and domestic business-to-business sales.
Inspire Medical (INSP) Q2 Earnings Beat, Gross Margin Rises
by Zacks Equity Research
Inspire Medical (INSP) reports strong second-quarter results, reflecting a 30% revenue increase. Its new technology and expanded U.S. presence promise growth and enhanced patient care.
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
by Zacks Equity Research
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
Baxter (BAX) Q2 Earnings Beat Estimates, '24 EPS View Raised
by Zacks Equity Research
Baxter (BAX) reports better-than-expected second-quarter earnings and sales. Its quarterly results reflect solid demand for a range of its medically essential products.
Stryker (SYK) Completes MOLLI's Acquisition to Boost Business
by Zacks Equity Research
Stryker (SYK) completes of the acquisition of MOLLI, a privately held company, to strengthen its commitment to advancing surgical solutions in breast cancer care.
CooperCompanies (COO) Acquires obp Surgical to Boost Portfolio
by Zacks Equity Research
CooperSurgical, a unit of CooperCompanies (COO), acquires obp Surgical for $100 million, adding innovative single-use surgical retractors and suction devices to its portfolio.
Zacks.com featured highlights include Universal Health Services, General Motors, Unum and PVH
by Zacks Equity Research
Universal Health Services, General Motors, Unum and PVH have been highlighted in this Screen of The Week article.
Acadia Healthcare (ACHC) Shares Up 12% on Q2 Earnings Beat
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q2 results reflect higher revenue per patient day and increased patient days. It currently estimates 2024 adjusted EPS within $3.45-$3.65 compared with the earlier view of $3.40-$3.70.
Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics
by Zacks Equity Research
Microbot Medical (MBOT) announces an agreement with Emory University to explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system.
Inspire Medical (INSP) Gets FDA Nod for Inspire V System
by Zacks Equity Research
Inspire Medical (INSP) secures FDA approval for its advanced Inspire V therapy system, featuring an innovative neurostimulator and Bluetooth technology for enhanced patient and physician control.
4 Low P/CF Stocks to Turn Market Volatility Into Opportunity
by Sumit Singh
Value investing is essentially about selecting stocks that are cheap but fundamentally sound. UHS, GM, UNM & PVH boast a low P/CF ratio.
Merit Medical (MMSI) Q2 Earnings & Revenues Beat, '24 View Up
by Zacks Equity Research
Merit Medical's (MMSI) second-quarter results reflect growth in earnings and revenues. Operating margin expands.
Ecolab (ECL) Sells Surgical Solutions Business to Medline
by Zacks Equity Research
Ecolab's (ECL) deal to sell its global surgical solutions business to Medline enables it to focus on infection prevention and instrument reprocessing while enhancing shareholders' returns.
Are Investors Undervaluing Universal Health Services (UHS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights Universal Health Services, Tenet Healthcare Corp., Century Communities and Magnite
by Zacks Equity Research
Universal Health Services, Tenet Healthcare Corp., Century Communities and Magnite are part of the Zacks Screen of the Week article.
QuidelOrtho (QDEL) Q2 Earnings Beat Estimates, U.S. Sales Down
by Zacks Equity Research
QuidelOrtho's (QDEL) second-quarter results reflect growth in revenues. However, gross profit continues to decline.
CONMED (CNMD) Q2 Earnings Beat, Sales Rise Y/Y, '24 View Cut
by Zacks Equity Research
CONMED (CNMD) beats second-quarter earnings estimates on the back of higher revenues and lower costs and expenses. However, the result reflects the continued impact of supply chain issues.
4 Stocks Trading Near 52-Week High That Can Climb Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like UHS, THC, CCS and MGNI that are seeing price strength have a high chance of carrying the momentum forward.